Sign in

CIK 0001711754

  • Non-accelerated filer
  • Smaller reporting company

Inmune Bio, Inc.

Sign in to watch
Ticker
INMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
475205835
Phone
+1 858-964-3720
Business address
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL, 33432
  1. 4 Open-market buy President and CEO bought 6,300 shares at $6.41 ($40,383)
  2. 4 Open-market buy CFO, Treasurer & Secretary bought 10,700 shares at an average $6.42 ($68,649)
  3. 4 Grant or award Chief Scientific Officer acquired 23,590 shares (grant or award)
  4. 4 Grant or award President and CEO acquired 23,724 shares (grant or award)
  5. 4 Derivatives Options or other derivatives
  6. 4 Grant or award CFO, Treasurer & Secretary acquired 17,793 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Grant or award Director acquired 17,793 shares (grant or award)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Director bought 2,500 shares at $13.55 ($33,875)
  12. 4 Open-market sale Chief Scientific Officer sold 701 shares at $20.00 ($14,020)
  13. 4 Open-market sale CFO, Treasurer & Secretary sold 1,025 shares at $20.00 ($20,500)
  14. 4 Open-market sale President and CEO sold 3,626 shares at $20.00 ($72,520)
  15. 4 Open-market sale President and CEO sold 6,517 shares at $20.00 ($130,340)
  16. 4 Open-market sale Chief Scientific Officer sold 2,357 shares at $20.00 ($47,140)
  17. 4 Open-market sale CFO, Treasurer & Secretary sold 2,079 shares at $20.00 ($41,580)
  18. 4 Open-market sale President and CEO sold 23,616 shares at $20.00 ($472,320)
  19. 4 Open-market sale CFO, Treasurer & Secretary sold 1,155 shares at $20.00 ($23,100)
  20. 4 Open-market sale Chief Scientific Officer sold 400 shares at $20.00 ($8,000)

Page 4 of 8 · 142 filings